ICAGEN, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementIcagen Inc • December 10th, 2010 • Pharmaceutical preparations • New York
Company FiledDecember 10th, 2010 Industry JurisdictionIcagen, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: